OSGEN PHARMA

About our online store

Innovation. Quality. Results.
At Osgen Pharma, we don't just create formulations — we create possibilities.

At Osgen Pharma, we are driven by innovation, precision, and a commitment to improving pharmaceutical therapies.
Specializing in advanced particle engineering and formulation technologies, we help transform drug development through our proprietary mSAS® technology, enhancing solubility, stability, and therapeutic performance.

Our team combines deep scientific expertise with cutting-edge solutions to support partners across the pharmaceutical and biotech industries. Whether through custom research, contract manufacturing, or our own portfolio of improved therapeutics, Osgen Pharma is dedicated to delivering smarter, more effective healthcare solutions.

 

 

OSGEN PHARMA

OUR TEAM

In addition to enhancing the performance of client products, we also apply our mSAS® technology platform in non-competing areas to Osgen’s own in-house therapeutic pipeline. Our assets address important areas of unmet clinical need, and each offers distinct advantages, whether through improved delivery, a novel route of administration, improved stability, or our unique ‘formulation in a particle’ approach.

Osgen are actively seeking co-development and licensing opportunities to progress our assets to market.

   

Board Of Directors

Patel Mikesh

Founder and Group Managing Director

Katie Dawson-Scott

Chief Financial Officer (CFO)

Sergey Coleman

Chief Operating Officer (COO)

Professor Emeritus Yohan Eric Osborne

  Head Of Research And Development

Anita Winterburn

 Sales Manager

Dr. Bryan Günter

 Chief Procurement Officer(CPO)

OUR STAFFS

Management

BRIAN MATLOCK

EVA MENDLOVA

DANIEL RIVERA

TIKRITY MISTIKA

JAMES GRENVILLE WOODLEY

THOMAS WEESLEY

MAUREEN CHEN